Lazard Asset Management
DTIL icon

Lazard Asset Management’s Precision BioSciences DTIL Stock Holding History

Lazard Asset Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-118
Closed -$1K – 2343
2024
Q3 		$1K Buy
118
+36
+44% +$347 ﹤0.01% 2142
2024
Q2 		$0 Buy
+82
New +$966 ﹤0.01% 2283
2023
Q2 		– Sell
-254
Closed -$5K – 2351
2023
Q1 		$5K Buy
254
+42
+20% +$1.38K ﹤0.01% 2162
2022
Q4 		$7K Buy
+212
New +$8.38K ﹤0.01% 2230
2022
Q1 		– Sell
-39
Closed -$8K – 2375
2021
Q4 		$8K Sell
39
-248
-86% -$69.3K ﹤0.01% 2138
2021
Q3 		$99K Buy
287
+58
+25% +$19.7K ﹤0.01% 1427
2021
Q2 		$86K Buy
+229
New +$68.8K ﹤0.01% 1395

Other funds holding DTIL

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

Lazard Asset Management's DTIL Position: Q4 2024 in Review

Lazard Asset Management sold out of Precision BioSciences (DTIL) in Q4 2024, closing a stake of 118 shares — an estimated $1K sold.

Lazard Asset Management first reported a position in DTIL in Q2 2021 and held it in 7 quarters. The position peaked at $99K in Q3 2021. 55 funds tracked by Wall St. Rank hold DTIL as of Q4 2024.

  • Lazard Asset Management reported no remaining Precision BioSciences position as of Q4 2024 after selling out during the quarter.
  • Lazard Asset Management sold 118 Precision BioSciences shares in Q4 2024, an estimated $1K.
  • Lazard Asset Management first reported a position in Precision BioSciences in Q2 2021 and held it in 7 quarters.
  • Lazard Asset Management's Precision BioSciences position peaked at $99K in Q3 2021.
  • 55 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2024.

Based on Lazard Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.